About Pfenex, Inc. (adapted from Pfenex, Inc. prospectus):
They are a clinical-stage biotechnology company engaged in the development of difficult to manufacture and high-value proteins, initially focused on biosimilar therapeutics, or biosimilars.

This description is adapted from Pfenex, Inc. prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.